Welcome To MedWorld Advisors!

In a somewhat unexpected move with positive implications for the MedTech industry, the Federal Reserve (Fed) in September opted for a 0.5% interest rate cut.

Selling your business is usually the penultimate milestone in a business owner’s career. A lot depends on its success, including financial longevity, continued legacy and even personal pride. On this episode, hear Dave discuss common mistakes as well as best practices for avoiding those mistakes.

Hosted by our founders CEO Florence Joffroy-Black, and Managing Director Dave Sheppard, watch the webinar to find out how M&A changes the MedTech landscape and its impacts on those involved in manufacturing medical devices and equipment.

From our perspective in working with private equity (PE) and strategic companies in 2024, mergers and acquisitions (M&A) continues to be highly active in medtech.

In our October column in ODT Magazine, we discuss how ASCs foster technological innovation that benefits both orthopedic implant developers and the centers themselves.

The election will stimulate more activity—depending, of course, on the political party that wins the presidency and control of the U.S. Congress.

On October 17, 2024 at 2PM ET, join us for an insightful webinar presented by Managing Director Daniel Sheppard, where we’ll dive into the latest trends and forecasts in Healthcare M&A.

You won't want to miss Managing Director Daniel Sheppard discuss Cross-Border Deals in Healthcare M&A during this webinar being held October 11 2024 at 8AM PT.

The anticipated reductions in U.S. federal interest rates present opportunities for medical industry manufacturers and may also benefit those owners among us that are looking to sell.

CentralReach, the leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, announces the acquisition of Behavior Sciences Technology (BST), a research-backed treatment fidelity platform designed to collect, measure, and track treatment fidelity for Applied Behavior Analysis (ABA) therapy in a standardized way.